531592 Stock Overview
Genpharmasec Limited engages primarily in dealing of pharmaceutical products in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Genpharmasec Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹2.29 |
52 Week High | ₹8.71 |
52 Week Low | ₹2.02 |
Beta | -0.62 |
1 Month Change | 2.69% |
3 Month Change | -59.97% |
1 Year Change | -26.37% |
3 Year Change | -74.21% |
5 Year Change | -86.20% |
Change since IPO | -94.51% |
Recent News & Updates
Recent updates
Shareholder Returns
531592 | IN Trade Distributors | IN Market | |
---|---|---|---|
7D | -3.4% | -0.7% | 1.4% |
1Y | -26.4% | 66.6% | 46.1% |
Return vs Industry: 531592 underperformed the Indian Trade Distributors industry which returned 67.6% over the past year.
Return vs Market: 531592 underperformed the Indian Market which returned 45% over the past year.
Price Volatility
531592 volatility | |
---|---|
531592 Average Weekly Movement | 6.9% |
Trade Distributors Industry Average Movement | 6.6% |
Market Average Movement | 6.8% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 531592's share price has been volatile over the past 3 months.
Volatility Over Time: 531592's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 9 | n/a | www.genpharmasec.com |
Genpharmasec Limited engages primarily in dealing of pharmaceutical products in India. It operates through two segments, Diagnostic Pharma Equipment and Trading in Securities. The Diagnostic Pharma Equipment segment distributes state-of-the-art diagnostic equipment comprising, i-STAT Analyser and its cartridges used in Intensive Care Units (ICUs) of hospitals to analyze blood for immediate test results.
Genpharmasec Limited Fundamentals Summary
531592 fundamental statistics | |
---|---|
Market cap | ₹1.27b |
Earnings (TTM) | ₹11.43m |
Revenue (TTM) | ₹264.24m |
110.9x
P/E Ratio4.8x
P/S RatioIs 531592 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
531592 income statement (TTM) | |
---|---|
Revenue | ₹264.24m |
Cost of Revenue | ₹213.57m |
Gross Profit | ₹50.67m |
Other Expenses | ₹39.24m |
Earnings | ₹11.43m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.021 |
Gross Margin | 19.18% |
Net Profit Margin | 4.33% |
Debt/Equity Ratio | 19.6% |
How did 531592 perform over the long term?
See historical performance and comparison